Abstract PD6-02: A randomized, controlled trial of high dose vs. standard dose vitamin D for aromatase inhibitor-induced arthralgia in breast cancer survivors

Autor: P Niravath, T Wang, SG Hilsenbeck, K Lipscomb, A Pavlick, S Jiralerspong, J Nangia, M Ellis, F Ademuyiwa, M Cherian, A Frith, C Ma, H Park, C Rigden, R Suresh, CK Osborne, MF Rimawi

Publikováno v: Cancer Research. 79:PD6-02

Background: Approximately half of women on aromatase inihbitor (AI) therapy develop AI-induced arthralgia (AIA), and many discontinue the medication because of this common side effect. While Vitamin D has been studied as a treatment for AIA, trial re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eac3d9d8f040e1676cb5155f5cf50cf9
https://doi.org/10.1158/1538-7445.sabcs18-pd6-02

IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer.

Autor: Xu L; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Peng F; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Luo Q; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Ding Y; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Yuan F; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA., Zheng L; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., He W; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang SS; Department of Chemistry, Rice University, Houston, TX 77005, USA., Fu X; Department of Pathology, Xijing Hospital, Xi'an, Shaanxi 710032, China., Liu J; Department of Pathology, Xijing Hospital, Xi'an, Shaanxi 710032, China., Mutlu AS; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Wang S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nehring RB; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Li X; College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, Sichuan 611130, China., Tang Q; College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, Sichuan 611130, China., Li C; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Lv X; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Dobrolecki LE; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Zhang W; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Han D; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Zhao N; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Jaehnig E; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Wang J; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Wu W; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Graham DA; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Li Y; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Chen R; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Peng W; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA., Chen Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Catic A; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Zhang Z; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang B; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Mustoe AM; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Koong AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Miles G; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Lewis MT; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Wang MC; HHMI Janelia Research Campus, Ashburn, VA 20147, USA., Rosenberg SM; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., O'Malley BW; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Westbrook TF; Therapeutic Innovation Center (THINC), and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Xu H; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang XH; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Osborne CK; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Li JB; Department of Genetics, Stanford University, Stanford, CA 94305, USA., Ellis MJ; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Rimawi MF; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Rosen JM; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Chen X; Department of Experimental Therapeutics, James P. Allison Institute, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Dun L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: xchen23@mdanderson.org.

Publikováno v: Cell [Cell] 2024 Dec 12; Vol. 187 (25), pp. 7248-7266.e34. Date of Electronic Publication: 2024 Oct 16.

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.

Autor: Ma CX; Washington University School of Medicine, St Louis, Missouri., Suman VJ; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Sanati S; Cedars-Sinai Medical Center, Los Angeles, California., Vij K; Washington University School of Medicine, St Louis, Missouri., Anurag M; Baylor College of Medicine, Houston, Texas., Leitch AM; University of Texas Southwestern Medical Center, Dallas., Unzeitig GW; Doctor's Hospital of Laredo, Laredo, Texas., Hoog J; Washington University School of Medicine, St Louis, Missouri., Fernandez-Martinez A; University of North Carolina at Chapel Hill., Fan C; University of North Carolina at Chapel Hill., Gibbs RA; Baylor College of Medicine, Houston, Texas., Watson MA; Washington University School of Medicine, St Louis, Missouri., Dockter TJ; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Hahn O; University of Chicago, Chicago, Illinois., Guenther JM; Saint Elizabeth Medical Center South, Edgewood, Kentucky., Caudle A; MD Anderson Cancer Center, Houston, Texas., Crouch E; Washington University School of Medicine, St Louis, Missouri., Tiersten A; Mount Sinai Hospital, New York, New York., Mita M; Cedars-Sinai Medical Center, Los Angeles, California., Razaq W; University of Oklahoma Health Sciences Center, Oklahoma City., Hieken TJ; Mayo Clinic, Rochester, Minnesota., Wang Y; Presbyterian Kaseman Hospital, Albuquerque, New Mexico., Rimawi MF; Baylor College of Medicine, Houston, Texas., Weiss A; University of Rochester, Rochester, New York., Winer EP; Yale School of Medicine, New Hartford, Connecticut., Hunt KK; MD Anderson Cancer Center, Houston, Texas., Perou CM; University of North Carolina at Chapel Hill., Ellis MJ; Baylor College of Medicine, Houston, Texas., Partridge AH; Dana-Farber/Partners CancerCare, Boston, Massachusetts., Carey LA; University of North Carolina at Chapel Hill.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Mar 01; Vol. 10 (3), pp. 362-371.

Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.

Autor: Lv X; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Lu X; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Cao J; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Luo Q; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Ding Y; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Peng F; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Pataer A; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lu D; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030, USA., Han D; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Malmberg E; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Chan DW; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Wang X; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Savage SR; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Mao S; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Yu J; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Peng F; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA., Yan L; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Meng H; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA., Maneix L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, USA., Han Y; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Chen Y; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yao W; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chang EC; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Catic A; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, USA., Lin X; Division of Surgical Oncology, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Miles G; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Huang P; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA., Sun Z; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA., Burt B; Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Wang H; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang J; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030, USA., Yao QC; Division of Surgical Oncology, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Zhang B; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., O'Malley BW; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA., Ellis MJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Early Oncology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Ying H; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen X; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2023 Sep 08; Vol. 381 (6662), pp. eabn4180. Date of Electronic Publication: 2023 Sep 08.

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.

Autor: Veeraraghavan J; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Gutierrez C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Pathology, Baylor College of Medicine, Houston, Texas., De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Davis R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Wang T; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain., Selenica P; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Sanchez K; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Nitta H; Roche Tissue Diagnostics, Tucson, Arizona., Kapadia M; Roche Tissue Diagnostics, Tucson, Arizona., Pavlick AC; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Galvan P; SOLTI Cancer Research Group, Barcelona, Spain., Rexer B; Vanderbilt University, Nashville, Tennesse., Forero-Torres A; University of Alabama-Birmingham, Birmingham, Alabama., Nanda R; University of Chicago, Chicago, Illinois., Storniolo AM; Indiana University School of Medicine, Indianapolis, Indiana., Krop IE; Dana Farber Cancer Institute, Boston, Massachusetts., Goetz MP; Mayo Clinic, Rochester, Minnesota., Nangia JR; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Wolff AC; Johns Hopkins University, Baltimore, Maryland., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Hilsenbeck SG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3101-3109.